Scientists at the TCG, together with collaborators at the University of Tasmania and the Save the Tasmanian Devil Program, have discovered a second transmissible cancer in Tasmanian devils. This second cancer, known as Devil Facial Tumour 2 (DFT2), causes tumours that are grossly indistinguishable from the first-discovered transmissible cancer in Tasmanian devils (now known as DFT1). However, DFT2 bears no detectable genetic similarity to DFT1. This astonishing discovery has just been published in Proceedings of the National Academy of Science. Further information is also available on the University of Cambridge website.